Hamps Bio debuts on BSE SME with a 90% premium, Listing at Rs 96.90 against issue price of Rs 51

Hamps Bio, a pharmaceutical products supplier, which ran its IPO from December 13 to December 17 made its debut on the BSE SME platform on Friday (December 20) listing at Rs 96.90 over the issue price of Rs 51. The shares of the company debuted at a premium of 90 per cent on the BSE SME platform.

Grey market Premium (GMP) of Hamps Bio IPO

Hours before the official listing of the company on the Indian bourses, the GMP of Hamps Bio IPO was trading at Rs 60, with an estimated listing of Rs 111 per share, marking a 117.65 per cent gain in the grey market, an unofficial marketplace to trade shares.

Hamps Bio IPO – Subscription details

The SME public issue, garnered a 1,057 times subscription. The retail category lead the charge, with subscriptions soaring 1,342.04 times, while non-institutional investors (NII) subscribed 758.27 times.

Also Read: DAM Capital Advisors IPO 2024 Live Updates: Check IPO price band, subscription status, GMP price, and other details

Hamps Bio IPO consisted entirely of a fresh issue of 12.2 lakh shares, with an aim of raising Rs 6.22 crore. Priced at Rs 51 per share, the minimum application size was set at 2,000 shares, requiring retail investors to invest Rs 1,02,000.

Furthermore, for high-net-worth individuals (HNIs), the minimum investment was two lots, totaling to a sum of Rs 2,04,000.

The issue allocation of Hamps Bio IPO was structured among various investor categories as follows. Half of the shares, or 50 per cent, were reserved for Qualified Institutional Buyers (QIBs), while 35 per cent were allocated to retail investors. Furthermore, the remaining 15 per cent was set aside for Non-Institutional Investors (NIIs).

Purpose Behind the Fundraising

Hamps Bio plans to channel the IPO proceeds into growth-focused initiatives which includes purchasing advanced machinery for its FMCG division, then enhancing its brand visibility, and covering general corporate expenses.

Also Read: International Gemological Institute (IGI) Share Price, IPO Listing Live Updates: Check listing, date, time, GMP, and other details

Key Stakeholders in the Issue

Marwadi Chandarana Intermediaries Broker served as the book-running lead manager for the SME public issue. On the other side, Bigshare Services acted as the registrar.

 » Read More

Related Articles

2025 could set new records in luxury realty

Luxury sells. And, the capital leads in lapping it up. With this month’s landmark deal of a flat in Gurugram’s DLF Camellias for Rs 190 crore, luxury real estate in Delhi-NCR is on a new high. Among the top seven cities in India, Delhi-NCR stood out with a remarkable 64% share of luxury residential launches

GST Council defers decision on tax rates for health, life insurance premiums – What we know so far

The GST Council on December 21 again deferred a decision to exempt and cut taxes on health and life insurance premiums. The reason for this is that the ministers’ panel needs more time to reach a consensus on the matter. “Some members said more discussions required. We (GoM) will meet in January again,” Bihar Deputy

Hamdard: True Companion of Those in Pain

By Farooq Wani A commitment to giving back to society with a charitable and compassionate spirit has been at the core of the business model adopted and followed by the Delhi-based Hamdard Laboratories India during its 118 years of existence.  Hamdard originates from two Persian words – “Hum”, meaning “companion”, and “Dard” meaning “pain” –

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

2025 could set new records in luxury realty

Luxury sells. And, the capital leads in lapping it up. With this month’s landmark deal of a flat in Gurugram’s DLF Camellias for Rs 190 crore, luxury real estate in Delhi-NCR is on a new high. Among the top seven cities in India, Delhi-NCR stood out with a remarkable 64% share of luxury residential launches

GST Council defers decision on tax rates for health, life insurance premiums – What we know so far

The GST Council on December 21 again deferred a decision to exempt and cut taxes on health and life insurance premiums. The reason for this is that the ministers’ panel needs more time to reach a consensus on the matter. “Some members said more discussions required. We (GoM) will meet in January again,” Bihar Deputy

Hamdard: True Companion of Those in Pain

By Farooq Wani A commitment to giving back to society with a charitable and compassionate spirit has been at the core of the business model adopted and followed by the Delhi-based Hamdard Laboratories India during its 118 years of existence.  Hamdard originates from two Persian words – “Hum”, meaning “companion”, and “Dard” meaning “pain” –

8th Pay Commission Delay: Employees’ Federation plans nationwide agitation in new year – Details inside

8th Pay Commission: With the Centre ruling out any proposal to set up the 8th Central Pay Commission anytime soon, over 1 crore central government employees and pensioners have expressed their displeasure over the delay in announcing the next pay commission, which, according to them, should start its term from January 1, 2026. Amid this

Signature Global emerges as top developer along Dwarka Expressway post-pandemic: Square Yards

Signature Global has emerged as the market leader in the Dwarka Expressway region, as per a recent report by Square Yards which pegs the total annual residential new supply along Dwarka Expressway at 10,000 units per annum since 2020, compared to 5,000–7,000 new units launched per annum in the pre-pandemic period. According to Square Yards